References
- Pappas DA. Treatment of rheumatoid arthritis: tumor necrosis factor inhibitors. In: Hochberg MC, Silman A, Smolen JS, Weinblat ME, Weisman MH, editors. Rheumatoid arthritis. 1st ed. Philadelphia: Mosby, an affiliate of Elsevier; 2009. p. 337–49.
- den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2007;34(4):689–95.
- Mochizuki T, Momohara S, Ikari K, Okamoto H, Kobayashi S, Tsukahara S, et al. The serum concentration of infiiximab in cases of autologous blood donation for patients with rheumatoid arthritis. Mod Rheumatol. 2007;17(1):24–7.
- Nestorov I, Zitnik R, DeVries T, Nakanishi AM, Wang A, Banfield C. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. Br J Clin Pharmacol. 2006;62(4):435–45.
- Korth-Bradley JM, Rubin AS, Hanna RK, Simcoe DK, Lebsack ME. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother. 2000;34(2):161–4.
- Koike R, Takeuchi T, Eguchi K, Miyasaka N. Update on the Japanese guidelines for the use of infiiximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007;17(6):451–8.
- Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford). 2005;44(2):157–63.
- Rosandich PA, Kelley JT 3rd, Conn DL. Perioperative manage-ment of patients with rheumatoid arthritis in the era of biologic response modifiers. Curr Opin Rheumatol. 2004;16(3):192–8.
- Ruyssen-Witrand A, Gossec L, Salliot C, Luc M, Duclos M, Guignard S, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol. 2007;25(3):430–6.
- Fautrel B, Pham T, Mouterde G, Le Loet X, Goupille P, Guillemin F, et al. Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patients with rheumatoid arthritis. Joint Bone Spine. 2007;74(6):627–37.
- Corrao S, Pistone G, Arnone S, Calvo L, Scaglione R, Licata G. Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. Clin Rheumatol. 2007;26(9):1513–5.